Who owns AEGLEA BIOTHERAPEUTICS INC?
- Ticker: SYRE
- CUSIP Number: 00773j202
Tip: Access positions for across all investors
Analyze quarterly positions in Aeglea Biotherapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Aeglea Biotherapeutics stock
Who bought or sold AEGLEA BIOTHERAPEUTICS INC this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
FMR | 6.6M | $247M | 100% | Mar 2024 |
|
Perceptive Advisors | 2.6M | $97M | -2% | Mar 2024 |
|
VR Adviser | 2.2M | $82M | -8% | Mar 2024 |
|
Commodore Capital | 1.9M | $72M | 0% | Mar 2024 |
|
venBio Select Advisor | 1.8M | $40M | 15951% | Dec 2023 |
|
Adage Capital Partners GP | 1.1M | $42M | 100% | Mar 2024 |
|
Franklin Resources | 742k | $28M | 8% | Mar 2024 |
|
Citadel Advisors | 708k | $27M | 23% | Mar 2024 |
|
Wellington Management Company | 636k | $14M | 112% | Dec 2023 |
|
BlackRock | 557k | $21M | 2716% | Mar 2024 |
|
Braidwell | 515k | $20M | 0% | Mar 2024 |
|
Vanguard Group | 497k | $19M | 1160% | Mar 2024 |
|
Darwin Global Management | 473k | $18M | 100% | Mar 2024 |
|
Farallon Capital Management | 466k | $18M | 100% | Mar 2024 |
|
First Turn Management | 464k | $18M | 100% | Mar 2024 |
|
Fairmount Funds Management | 378k | $14M | 0% | Mar 2024 |
|
Geode Capital Management | 330k | $13M | 1132% | Mar 2024 |
|
Millennium Management | 320k | $12M | 195% | Mar 2024 |
|
Cormorant Asset Management | 250k | $9.5M | -73% | Mar 2024 |
|
Boxer Capital | 250k | $9.5M | 0% | Mar 2024 |
|
Logos Global Management | 250k | $9.5M | 67% | Mar 2024 |
|
Goldman Sachs Group | 240k | $9.1M | 100% | Mar 2024 |
|
Voloridge Investment Management | 188k | $7.1M | 100% | Mar 2024 |
|
Suvretta Capital Management | 162k | $6.2M | 0% | Mar 2024 |
|
Marshall Wace | 162k | $6.1M | 700% | Mar 2024 |
|
HighVista Strategies | 154k | $5.9M | 100% | Mar 2024 |
|
Dr. Jeffrey R. Jay, M.D. | 125k | $4.7M | 0% | Mar 2024 |
|
Walleye Trading Advisors | 112k | $4.2M | 100% | Mar 2024 |
|
Candriam Luxembourg S.C.A. | 105k | $4.0M | 100% | Mar 2024 |
|
Susquehanna International | 102k | $3.9M | 100% | Mar 2024 |
|
Woodline Partners | 101k | $3.8M | 100% | Mar 2024 |
|
Integral Health Asset Management | 100k | $3.8M | 100% | Mar 2024 |
|
Hrt Financial | 79k | $3.0M | 100% | Mar 2024 |
|
T. Rowe Price Associates | 79k | $3.0M | 100% | Mar 2024 |
|
Northern Trust | 66k | $2.5M | 100% | Mar 2024 |
|
Assenagon Asset Management | 64k | $2.4M | 100% | Mar 2024 |
|
TD Asset Management | 61k | $2.3M | 100% | Mar 2024 |
|
Qube Research & Technologies | 58k | $2.2M | 100% | Mar 2024 |
|
Morgan Stanley | 51k | $1.9M | 111178% | Mar 2024 |
|
ADAR1 Capital Management | 50k | $1.9M | 669% | Mar 2024 |
|
Cubist Systematic Strategies | 49k | $1.9M | 89% | Mar 2024 |
|
Barclays | 46k | $1.7M | 1% | Mar 2024 |
|
Swiss National Bank | 39k | $1.5M | 100% | Mar 2024 |
|
Bank of America Corporation | 36k | $1.4M | 100% | Mar 2024 |
|
Schonfeld Strategic Advisors | 36k | $1.3M | 100% | Mar 2024 |
|
Balyasny Asset Management | 32k | $1.2M | 100% | Mar 2024 |
|
Citigroup | 32k | $1.2M | 208% | Mar 2024 |
|
Soros Fund Management | 30k | $1.1M | 100% | Mar 2024 |
|
ExodusPoint Capital Management | 25k | $928k | 100% | Mar 2024 |
|
Credit Suisse | 22k | $837k | 100% | Mar 2024 |
|
Blackstone Group | 20k | $758k | 0% | Mar 2024 |
|
Global Endowment Management | 18k | $690k | -96% | Mar 2024 |
|
Fred Alger Management | 18k | $689k | 100% | Mar 2024 |
|
Eudaimonia Asset Management | 18k | $680k | 100% | Mar 2024 |
|
California State Teachers Retirement System | 18k | $675k | 100% | Mar 2024 |
|
Legal & General Group | 17k | $646k | 100% | Mar 2024 |
|
Virtu Financial | 16k | $615k | 100% | Mar 2024 |
|
Engineers Gate Manager | 16k | $594k | 100% | Mar 2024 |
|
Charles Schwab Investment Management | 15k | $569k | 100% | Mar 2024 |
|
New York State Common Retirement Fund | 15k | $556k | 3919% | Mar 2024 |
|
State of Wisconsin Investment Board | 15k | $555k | 100% | Mar 2024 |
|
Henderson Group | 14k | $530k | 100% | Mar 2024 |
|
Two Sigma Investments | 13k | $507k | -52% | Mar 2024 |
|
Scientech Research | 13k | $499k | 100% | Mar 2024 |
|
Legato Capital Management | 12k | $435k | 100% | Mar 2024 |
|
EFG Asset Management | 11k | $423k | 100% | Mar 2024 |
|
LMR Partners | 11k | $421k | 100% | Mar 2024 |
|
Polymer Capital Management | 11k | $399k | 100% | Mar 2024 |
|
Carlyle | 9.6k | $365k | 0% | Mar 2024 |
|
Squarepoint Ops | 8.2k | $310k | 100% | Mar 2024 |
|
Susquehanna Fundamental Investments | 8.1k | $306k | 100% | Mar 2024 |
|
Jane Street | 7.2k | $274k | 100% | Mar 2024 |
|
Chartwell Investment Partners | 6.8k | $259k | 100% | Mar 2024 |
|
Bank of New York Mellon | 6.1k | $230k | 100% | Mar 2024 |
|
Virtus ETF Advisers | 5.8k | $221k | -6% | Mar 2024 |
|
Arizona State Retirement System | 5.4k | $207k | 100% | Mar 2024 |
|
Tower Research Capital | 3.8k | $145k | 807% | Mar 2024 |
|
UBS Group | 2.6k | $99k | -30% | Mar 2024 |
|
Wells Fargo & Company | 2.2k | $85k | 9648% | Mar 2024 |
|
Deutsche Bank Aktiengesellschaft | 298.00 | $11k | 100% | Mar 2024 |
|
IFP Advisors | 114.00 | $2.5k | 0% | Dec 2023 |
|
Advisor Group Holdings | 83.00 | $3.1k | -71% | Mar 2024 |
|
Royal Bank of Canada | 56.00 | $2.0k | 100% | Mar 2024 |
|
Point72 | 22.00 | $847.000000 | 100% | Mar 2024 |
|
Jpmorgan Chase & Co | 11.00 | $417.000100 | -73% | Mar 2024 |
|
Pacific Capital Wealth Advisors | 8.00 | $303.000000 | 0% | Mar 2024 |
|
Who sold out of Aeglea Biotherapeutics?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
EcoR1 Capital | Dec 2023 | 887k | $19M |
BVF | Dec 2023 | 687k | $15M |
Rock Springs Capital Management | Sep 2023 | 137k | $1.7M |
Aisling Capital Management | Sep 2023 | 68k | $829k |
Acadian Asset Management | Sep 2023 | 12k | $145k |